Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.43 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | HPGD | P15428 | 3/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | ESR1 | P03372 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrazine SCHEMBL25410412 | 0.94 | TDP1 (0.42) | TDP1CYP2A6ALDH1A1HPGDCYP1A2 | |
| SCHEMBL364085 | 0.81 | ESR1 (0.52) | TDP1ALDH1A1HPGDCYP3A4HSD17B10 | |
| SCHEMBL27587540 | 0.81 | ESR1 (0.52) | TDP1ALDH1A1HPGDCYP3A4HSD17B10 | |
| SCHEMBL31508271 | 0.81 | ESR1 (0.52) | TDP1ALDH1A1HPGDCYP3A4HSD17B10 | |
| Ammonia Solution, Strong SCHEMBL27732115 | 0.79 | GPR84 (0.43) | TDP1CYP2A6ALDH1A1HPGDCYP1A2 | |
| SCHEMBL2641226 | 0.78 | ESR1 (0.47) | TDP1ALDH1A1HPGDCYP1A2CYP3A4 | |
| SCHEMBL1505828 | 0.78 | ALOX5 (0.55) | TDP1CYP2A6ALDH1A1HPGDCYP1A2 | |
| SCHEMBL49672 | 0.77 | ESR1 (0.55) | ALDH1A1HPGDHSD17B10KDM4EMEN1 | |
| SCHEMBL7084150 | 0.77 | GPR84 (0.44) | TDP1CYP2A6ALDH1A1HPGDCYP1A2 | |
| SCHEMBL28795643 | 0.76 | MEN1 (0.44) | TDP1CYP2A6ALDH1A1HPGDCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11569466-B2 | Light-emitting element, light-emitting device, electronic device, and lighting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2023-01-31 | — | — | US | disclosed |
| WO-2022172125-A1 | LIGHT EMITTING DEVICES, LIGHT EMITTING APPARATUS, ELECTRONIC DEVICE, AND LIGHTING DEVICE | 株式会社半導体エネルギー研究所 | 2022-08-18 | — | — | WO | disclosed |
| WO-2022172116-A1 | LIGHT-EMITTING DEVICE, LIGHT-EMITTING APPARATUS, ELECTRONIC EQUIPMENT, AND ILLUMINATION APPARATUS | 株式会社半導体エネルギー研究所 | 2022-08-18 | — | — | WO | disclosed |
| US-20170294594-A1 | Dibenzo[f,h]Quinoxaline Derivative, Method of Synthesizing the Same, Light-Emitting Element, Light-Emitting Device, Electronic Appliance, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2017-10-12 | — | — | US | disclosed |
| US-9666825-B2 | Light-emitting element, light-emitting device, electronic device, and lighting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2017-05-30 | — | — | US | disclosed |
| US-9540315-B2 | Triarylamine derivative, light-emitting substance, light-emitting element, light-emitting device, and electronic device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2017-01-10 | — | — | US | disclosed |
| US-20160293877-A1 | Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2016-10-06 | — | — | US | disclosed |
| US-20150141697-A1 | Triarylamine Derivative, Light-Emitting Substance, Light-Emitting Element, Light-Emitting Device, and Electronic Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-05-21 | — | — | US | disclosed |
| US-8815412-B2 | Quinoxaline derivative, and light-emitting element, light-emitting device, and electronic appliance using the quinoxaline derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2014-08-26 | — | — | US | disclosed |
| US-20090184633-A1 | Quinoxaline Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Appliance Using the Quinoxaline Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2009-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11569466-B2 | Light-emitting element, light-emitting device, electronic device, and lighting device | LEO1, SUN2, ESR1 | TDP1 3708/4885CYP2A6 283/4885ALDH1A1 589/4885 |
| US-20150141697-A1 | Triarylamine Derivative, Light-Emitting Substance, Light-Emitting Element, Light-Emitting Device, and Electronic Device | AHR, NAT1, TAAR1 | TDP1 1928/4885CYP2A6 163/4885ALDH1A1 76/4885 |
| US-20090184633-A1 | Quinoxaline Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Appliance Using the Quinoxaline Derivative | H1-0, NQO2, GDI1 | TDP1 1566/4885CYP2A6 1318/4885ALDH1A1 499/4885 |
| US-20170294594-A1 | Dibenzo[f,h]Quinoxaline Derivative, Method of Synthesizing the Same, Light-Emitting Element, Light-Emitting Device, Electronic Appliance, and Lighting Device | DDT, DHODH, INF2 | TDP1 1805/4885CYP2A6 543/4885ALDH1A1 1183/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.